AK Struckmeier, A Radermacher, M Fehrenz… - Journal of Cancer …, 2023 - Springer
Abstract Purpose Strategies for Indolamine-2, 3-dioxygenase 1 (IDO1) inhibition in cancer
immunotherapy once produced encouraging results, but failed in clinical trials. Recent …